Standout Papers
- Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma (2021)
- Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. (1998)
- Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update (2015)
- 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines (2000)
Immediate Impact
7 by Nobel laureates 5 from Science/Nature 60 standout
Citing Papers
Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial
2023 Standout
Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline
2022 Standout
Works of James L. Wade being referenced
Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor–Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202
2017
Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor–Induced Musculoskeletal Pain: SWOG S0927
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| James L. Wade | 4205 | 1944 | 1294 | 1367 | 150 | 7.4k | |
| J.W.R. Nortier | 3451 | 1211 | 939 | 969 | 157 | 7.6k | |
| Jeffrey Crawford | 6647 | 2720 | 1369 | 2028 | 199 | 10.0k | |
| Karen H. Antman | 3425 | 3227 | 1186 | 614 | 144 | 8.3k | |
| Lee S. Schwartzberg | 5888 | 2294 | 1334 | 839 | 419 | 10.0k | |
| Joanne Mortimer | 4168 | 2920 | 1254 | 900 | 256 | 9.0k | |
| Jeffrey Crawford | 4928 | 1944 | 1063 | 1070 | 107 | 6.6k | |
| Martin D. Abeloff | 2857 | 919 | 1442 | 528 | 117 | 5.9k | |
| M. Robert Cooper | 3395 | 1285 | 902 | 623 | 138 | 7.1k | |
| Paul Sabbatini | 3870 | 1837 | 1758 | 695 | 179 | 8.5k | |
| Daniel D. Karp | 4694 | 3760 | 2856 | 760 | 213 | 9.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...